13 research outputs found

    Clinical evaluation of Moro (<i>Citrus sinensis</i> (L.) Osbeck) orange juice supplementation for the weight management

    Get PDF
    <div><p>In the last years, several studies have recently evaluated the beneficial effects of red orange juice (<i>Citrus sinensis</i> (L.) Osbeck) and its active components in weight management and obesity. Moro orange is a cultivar of red orange, particularly rich in active compounds such as anthocyanins, hydroxycinnamic acids, flavone glycosides and ascorbic acid, which displays anti-obesity effects in <i>in vitro</i> and <i>in vivo</i> studies. In this clinical study, the effect of a Moro juice extract (Morosil<sup>®</sup>, 400 mg/die) supplementation was evaluated in overweight healthy human volunteers for 12 weeks. Results showed that Moro juice extract intake was able to induce a significant reduction in body mass index (BMI) after 4 weeks of treatment (<i>p</i> < 0.05). Moreover, in subjects treated with Moro extract, body weight, BMI, waist and hip circumference were significantly different from the placebo group (<i>p</i> < 0.05). In conclusion, it could be suggested that the active compounds contained in Moro juice have a synergistic effect on fat accumulation in humans and Moro juice extract can be used in weight management and in the prevention of human obesity.</p></div

    Localization of tPA-like immunoreactivity in RT4-D6P2T cells stimulated with PACAP, maxadilan, VIP or brain-derived neutrophic factor (BDNF).

    No full text
    <p>Depicted are representative immunocytofluorescence photomicrographs (<b>a</b>) and bar graphs showing semi-quantification of fluorescent intensity (<b>b</b>) in cells in which 1° Ab was omitted (Neg. Control), were left untreated (Control) or were treated with the indicated concentrations of PACAP, the PAC<sub>1</sub> agonist (maxadilan), VIP or BDNF for 24h. Briefly, RT4-D6P2T cells cultured on glass cover slips were fixed in 4% para-formaldehyde, permeabilized with 0.2% Triton X-100, blocked with 0.1% BSA in PBS and then probed with the tPA antibody (1:50 dilution). Detection was then performed using an Alexa fluor 488-conjugated secondary antibody. Nuclei were counterstained with DAPI (#940110 Vector Laboratories). Immunofluorescent images were captured using an Axiovert 40 fluorescence microscope (Carl Zeiss Inc.). Each condition was reproduced in three dishes <i>per</i> experiment. Representative photomicrographs were taken from at least three fields <i>per</i> dish in a fixed pattern. Original magnification 40X. Scale bar = 30μm.</p

    PACAP- and BDNF-mediated induction of tPA expression and activity involves both the MAPK<sup>Erk1/2</sup> and Akt/cAMP-responsive element binding protein (CREB) signaling pathways.

    No full text
    <p>Representative zymographic (<b>a</b>) and Western blot analyses (<b>b</b>) demonstrating the effects of 10<sup>−7</sup>M PACAP or 2x10<sup>−9</sup>M BDNF treatment on tPA and uPA activity (<b>a</b>) and tPA protein expression (<b>b</b>) in RT4-D6P2T cells after 24h. tPA and uPA activities were determined by zymography as detailed in MATERIALS AND METHODS. The representative picture shows lytic areas (white bands) on a Coomassie-stained gel (blue background) that correspond to the predicted molecular weight for tPA (64-70kDa) and uPA (~50kDa). Bar graphs depicted below the gel indicate the relative activity of each plasminogen activator, measured as the mean band intensity obtained from at least three separate determinations and calculated using the ImageJ software. <i>*p<0.05 or **p<0.01 Vs Control</i>; ANOVA followed by Dunnett’s <i>post-hoc</i> test. (<b>c</b> and <b>c’</b>) Activation of the MAPK<sup>Erk1/2</sup> and Akt/CREB signalling cascades was assessed by measuring Erk1/2, Akt and CREB phosphorylation at the indicated phospho-sites using the same procedures described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117799#pone.0117799.g001" target="_blank">Fig. 1</a>. Relative activation was calculated by normalizing each phospho-protein level over the corresponding unphosphorylated protein, which also served as loading control. Each plotted result represents the mean ± SEM from three separate experiments. <i>**p<0.01 Vs Control</i>; ANOVA followed by Dunnett’s <i>post-hoc</i> test. n.s. = not significant.</p

    BDNF boosts endogenous PACAP/PAC<sub>1</sub> receptor signaling to induce tPA expression in RT4-D6P2T cells.

    No full text
    <p>Western blots and related quantifications (<b>a</b> and <b>b</b>) showing the effect of 2x10<sup>−9</sup>M BDNF treatment on PACAP peptide and PAC<sub>1</sub> receptor expression at different exposure times (0, 6, 12 and 24h). For experimental procedures please refer to the appropriate section in MATERIALS AND METHODS. Results in (<b>b</b>) are the mean ± SEM of normalized values obtained from at least three separate experiments. β-tubulin was used as the loading control. <i>*p<0.05 or **p<0.01 Vs Control</i>; ANOVA followed by Tukey <i>post-hoc</i> test. Inhibitory effects of the non-specific PAC<sub>1</sub>/VPAC type receptor antagonist PACAP6-38 (10μM) on tPA protein expression were determined by Western blots (<b>c</b>). Cells were either left untreated (control) or pretreated with PACAP6-38 in the absence or presence of PACAP or BDNF and tPA expression was evaluated. Quantification of bands was performed by normalizing tPA band density to that of β-tubulin, which was used as loading control. Each experiment was reproduced three times with similar results. Depicted in the bar graph are the average ratios ± SEM. <i>*p<0.05 or ***p<0.001 Vs Control</i>; ANOVA followed by Tukey <i>post-hoc</i> test.</p

    Serum withdrawal induces tPA expression in RT4-D6P2T cells.

    No full text
    <p>Photomicrographs (<b>a</b>) and relative quantifications of tPA-like immunoreactivity in RT4-D6P2T cells (<b>a’</b>) cultured either in the presence (Control) or absence of serum (Serum Starved) after 24h. Immunofluorescent images were captured using an Axiovert 40 fluorescence microscope (Carl Zeiss Inc.). Each condition was reproduced using at least three dishes <i>per</i> experiment. Representative photomicrographs were taken from at least three fields <i>per</i> dish in a fixed pattern. Original magnification 40X. Scale bar = 30μm. Details on the procedure can be found in MATERIALS AND METHODS section. (<b>a’</b>) Bar graph depicts the relative fluorescence ± SEM, expressed as arbitrary units. <i>**p<0.01 Vs Control</i>, as determined using the unpaired two-tailed Student <i>t</i>-test. (<b>b</b>) Representative immunoblot and related quantifications of bands obtained by resolving cell lysates from cultures treated as indicated above. Normalized tPA expression levels were calculated using β-tubulin as the loading control. Each result displayed in the bar graph represents the mean ± SEM from three independent experiments. *<i>*p<0.01 Vs Control</i>; Unpaired two-tailed Student <i>t</i>-test. Ctrl = 10% FBS cultured RT4-D6P2T cells after 24h. SS = Serum starved cells.</p

    Dose- and time-dependent effects of PACAP on tissue plasminogen activator (tPA) mRNA and protein expression.

    No full text
    <p>Representative immunoblots and densitometric analyses (<b>a – b</b>) showing the effects of increasing concentrations of PACAP38 (10<sup>−10</sup>M to 10<sup>−6</sup>M, respectively) or (<b>a</b>) of a single concentration of the peptide (10<sup>−7</sup>M) on tPA protein expression at different time points (0, 3, 6, 12, 24, 48h). Protein extracts (20μg) obtained from rat RT4-D6P2T cultures grown as described were separated by SDS-PAGE and transferred to nitrocellulose membranes. Then, membranes were incubated using a rabbit anti-tPA (1:300, sc-15346, Santa Cruz Biotechnology) and a rabbit anti-β-tubulin antibody (H-235, cat n. sc-9104, Santa Cruz Biotechnology; 1:500) and scanned with an Odyssey Infrared Imaging System, as described in Materials and Methods section. Densitometric analyses were performed using the ImageJ software and values obtained were normalized to β-tubulin, which was used as loading control. Results are expressed as the average ratios ± S.E.M. from at least three independent determinations. <i>*p<0.05 or **p<0.01 Vs untreated control or t0</i>, as determined by One-way ANOVA followed by Dunnett’s <i>post-hoc</i> test. Kinetics of tPA mRNA expression in untreated cells (Ctrl) or following treatment with 10<sup>−7</sup>M PACAP38 at different times (0, 1, 2, 4, 6, 8, 10, 12, 24 and 48h, respectively) as determined by quantitative real time PCR analyses (<b>c</b>). Results are presented as mean fold changes with respect to Ctrl at the same experimental time ± S.E.M. Fold changes of tPA gene expression were obtained after normalization to the endogenous ribosomal protein S18 (housekeeping gene) and then calculated using the comparative ΔCt method. Baseline expression levels of the control group (Ctrl) were set to 1. Experiments were performed three times independently. <i>*p<0.05 or ***p<0.001 vs Ctrl at the same experimental time</i>, as determined by ANOVA followed by Dunnett’s <i>post-hoc</i> comparison.</p

    Western blot analysis on cellular proteins separated into nuclear and cytoplasmic fractions from sNF96.2 cells.

    No full text
    <p><b>A</b>: Whole cell lysate (W), cytosolic (C), and nuclear (N) fractions were immunoblotted with C-19 WT1 antibody. <b>B</b>: Results were expressed as optical density (O.D.). *p<0.05 relative to whole cell lysate.</p

    Time-course of siWT1 on sNF96.2.

    No full text
    <p>Western blot analysis on cells treated with 50 nM p-siWT1 (<b>A</b>) or s-siWT1 (<b>B</b>), compared to those treated with scrambled siNEG. siWT1 results were expressed as fold change compared to siNEG ones (<b>A1</b> and <b>B1</b> for p-siWT1 and s-siWT1, respectively). *p<0.05. <b>C</b>: Staining of WT1 protein in sNF96.2 cell treated with 50 nM siNEG, p-siWT1 or s-siWT1. Scale bars: 20 µm.</p

    WT1 expression in sNF96.2 cells determined by immunocytochemistry.

    No full text
    <p>Immunofluorescence positive cells to 6F-H2 (<b>B</b>) and C-19 WT1 (<b>E</b>) antibody are merged (<b>C</b> and <b>F</b>, respectively) with their own DAPI stained nuclei (<b>A</b> and <b>D</b>). Scale bars: 50 µm.</p

    siWT1 on apoptosis.

    No full text
    <p>Effects of siWT1 on cleaved caspase-3 expression in sNF96.2 cells treated with 50 nM for 48 and 72 hours determined by Western blot analysis. As a positive apoptosis control (PC), cell lysate of human fibroblasts exposed to 0.1 mM of staurosporine for 24 hours was used <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0114333#pone.0114333-Johanssonn1" target="_blank">[83]</a>.</p
    corecore